TY - JOUR
T1 - Erratum
T2 - A phase 2 randomized, double-blind, placebo-controlled study of the safety and efficacy of talactoferrin in patients with severe sepsis
AU - TLF LF-0801 Investigator Group
AU - Arroliga, Alejandro
AU - Balk, Robert
AU - Cannon, Chad
AU - Dean, Nathan
AU - Dellinger, Phillip
AU - Dennen, Paula
AU - Figueroa, Juan
AU - Fletcher, Eugene
AU - Guntupalli, Kalpalatha K.
AU - Huang, David T.
AU - Levy, Mitchell
AU - Lo, Takkin
AU - Malik, Imrana
AU - Margolis, Benjamin
AU - Matuschak, George
AU - Moore, Laura
AU - Moran, Gregory J.
AU - Moretti, Eugene
AU - Morris, Peter
AU - Panacek, Edward
AU - Rivers, Emanual
AU - Schmidt, Greg
AU - Seneff, Michael G.
AU - Steingrub, Jay
AU - Taylor, Robert
PY - 2014/5
Y1 - 2014/5
UR - https://www.scopus.com/pages/publications/84899486244
UR - https://www.scopus.com/pages/publications/84899486244#tab=citedBy
UR - https://www.mendeley.com/catalogue/c39b371b-8fb2-36eb-9b28-9eb5d915c3b7/
U2 - 10.1097/CCM.0000000000000348
DO - 10.1097/CCM.0000000000000348
M3 - Comment/debate
AN - SCOPUS:84899486244
SN - 0090-3493
VL - 42
SP - e390
JO - Critical Care Medicine
JF - Critical Care Medicine
IS - 5
ER -